Jan 26, 2022 07:07AM
Jan 26, 2022 07:00AM
Nov 9, 2021 08:05AM
Nov 8, 2021 04:10PM
Sep 27, 2021 04:06PM
Sep 27, 2021 04:05PM
Sep 1, 2021 04:05PM Ziopharm Oncology to Participate in September Investor Conferences
Aug 30, 2021 08:32AM
Aug 30, 2021 08:30AM
Aug 9, 2021 04:05PM
May 19, 2021 04:11PM
May 19, 2021 04:05PM
May 6, 2021 04:02PM
Feb 25, 2021 04:05PM Ziopharm Oncology Provides Leadership and Corporate Updates; Reports Fourth Quarter and Full Year 2020 Financial Results
Feb 5, 2021 09:03AM
Feb 5, 2021 09:00AM
Jan 14, 2021 08:03AM
Jan 14, 2021 08:00AM
Dec 21, 2020 04:03PM
Dec 21, 2020 04:01PM
Dec 4, 2020 08:30AM Ziopharm Details Actions in Response to Shareholder Feedback
Nov 27, 2020 05:32PM
Nov 20, 2020 11:00AM
Nov 19, 2020 09:03AM
Nov 19, 2020 09:00AM
Nov 17, 2020 04:15PM
Nov 16, 2020 08:33AM
Nov 16, 2020 08:30AM Ziopharm Oncology Appoints Mary Thistle to Board of Directors
Nov 5, 2020 04:02PM
Nov 2, 2020 09:00AM
Sep 22, 2020 08:33AM
Sep 22, 2020 08:30AM
Sep 15, 2020 08:30AM
Sep 14, 2020 08:31AM
Sep 14, 2020 08:30AM Ziopharm Oncology Granted Rare Pediatric Disease Designation for Controlled IL-12 for the Treatment of DIPG
Aug 6, 2020 04:04PM
Jul 22, 2020 08:33AM
Jul 22, 2020 08:30AM
Jul 10, 2020 09:26AM
Jul 9, 2020 04:20PM
Jul 9, 2020 04:15PM
Jul 8, 2020 08:34AM Ziopharm Oncology (ZIOP) Reports First DIPG Patient in Phase 1/2 Trial of Controlled IL-12 for Treatment of Pediatric Brain Tumors
Jul 8, 2020 08:30AM
Jun 22, 2020 08:10AM
Jun 22, 2020 08:00AM
Jun 15, 2020 08:00AM
May 29, 2020 08:13AM
May 29, 2020 08:00AM
May 27, 2020 04:33PM Ziopharm Oncology (ZIOP) announces Dr. David Mauney stepping down as President
May 27, 2020 04:15PM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All